Structure-Activity and Structure-Degradation Relationship Studies of 2-Amino-6-(benzimidazol-2-ylmethyl)-N9-heteroarylpurines as Potent and Selective CDK12/13 Inhibitors and Cyclin K Degraders.
Journal of medicinal chemistry
View this publicationJournal of medicinal chemistry
View this publicationNature communications
View this publicationACS medicinal chemistry letters
View this publicationThe Journal of experimental medicine
View this publicationMolecular cell
View this publicationNature immunology
View this publicationFrontiers in cell and developmental biology
View this publicationNature immunology
View this publicationChemical communications (Cambridge, England)
View this publicationThe EMBO journal
View this publication